Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 1,521 shares at $30.88 ($47K) on 2023-02-08, disclosed to the SEC on 2023-02-10.
Open-market sale of $47k DNLI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |